글로벌 전구세포 기반 시장 – 2028년까지의 산업 동향 및 예측

전구세포 기반 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 전구세포 기반이 2021-2028년 예측 기간 동안 약 7.80%의 CAGR을 보일 것이라고 분석했습니다. 끊임없이 증가하는 노령 인구, 신약 및 치료법 개발을 위한 연구 개발 활동의 급증, 의료 인프라 개발을 위한 지출 증가 는 전구세포 기반 시장 성장에 기인하는 주요 요인입니다.

조혈 세포라고도 알려진 전구 세포는 골수에 존재하는 줄기 세포입니다. 전구 세포는 분열하여 새롭고 다른 세포주를 생성할 수 있습니다. 전구 세포 기반 치료는 광범위한 신경계 질환을 치료하는 데 사용됩니다.

파킨슨병(PD)의 유병률 증가는 시장 성장을 촉진하는 주요 요인입니다. 의료 인프라 개발에 대한 지출 증가와 고급 게놈 세포 기반 기술에 대한 인식 증가도 시장 성장을 촉진하는 다른 요인입니다. 개인의 가처분 소득 증가와 재생 의학에 대한 정부의 자금 지원 증가는 수익성 있는 시장 성장 기회를 창출할 다른 간접적인 결정 요인입니다.

그러나 줄기세포 제조와 관련된 높은 비용은 시장 성장에 큰 도전이 될 것입니다. 또한 동물 실험과 관련된 윤리적 우려와 숙련된 전문가의 부족이 시장 성장률을 더욱 떨어뜨릴 것입니다. 제품 개발에 대한 불분명한 규제 지침도 시장 성장률을 중단시킬 것입니다.

This progenitor cell-based market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on progenitor cell-based market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Progenitor Cell-Based Market Scope and Market Size

The progenitor cell-based market is segmented on the basis of type, therapeutic application, cell source and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the progenitor cell-based market is segmented into allogeneic stem cell and autologous stem cell. Allogeneic stem cell segment is sub-segmented into musculoskeletal disorders, wounds and injuries, surgeries, acute graft-versus-host disease (AGVHD) and others. Autologous stem cell segment is sub-segmented into wounds and injuries, cardiovascular diseases, gastrointestinal diseases and others.
• On the basis of therapeutic application, the progenitor cell-based market is segmented into musculoskeletal disorders, wound and injuries, neurology, cardiovascular diseases (CVD), gastrointestinal diseases, surgeries and others.
• On the basis of cell source, the progenitor cell-based market is segmented into adipose tissue- derived mesenchymal stem cells, bone marrow- derived mesenchymal stem cells, embryo/ cord blood stem cells and others.  
• On the basis of end user, the progenitor cell-based market is segmented into laboratory, hospitals, research institute and others.

Progenitor Cell-Based Market Country Level Analysis

The progenitor cell-based market is analysed and market size insights and trends are provided by country, type, therapeutic application, cell source and end user as referenced above.

The countries covered in the progenitor cell-based market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the progenitor cell-based market owing to the rising expenditure for the development of research and development proficiencies, surge in the government funding for   regenerative medicine and favourable reimbursement scenario in this region. Asia-Pacific is projected to score highest growth rate and exhibit the highest CAGR for the forecast period. This is because of the rising expenditure to develop healthcare infrastructure, growing prevalence of neurological disorders, rising product launch by the market players and increasing personal disposable income.

The country section of the progenitor cell-based market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The progenitor cell-based market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Progenitor Cell-Based Market Share Analysis

전구세포 기반 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 전구세포 기반 시장과 관련된 회사의 초점에만 관련이 있습니다.

전구세포 기반 시장 보고서에서 다루는 주요 기업으로는 Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc., Gilead Sciences, Inc., Thermo Fisher Scientific Inc., AbbVie Inc., F. Hoffmann-La Roche Ltd, Pfizer Inc., Merck & Co., Inc., Abbott, Novartis AG, Baxter, STEMCELL Technologies Inc., Organogenesis Inc., Vericel Corporation, Takara Bio Inc., Alcon Vision LLC, Cryo-Cell, Osiris 및 ThermoGenesis Holdings, Inc. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-46714